FHIT promotes the apoptosis of QBC939 by reducing the expression of cyclin D1

Hepato-Gastroenterology

Volumn 58, Issue 107-108, 2011, Pages 713-718

  Huang, Qiang ^a   Xie, Fang ^a   Tang, Zhigang ^a   Liu, Chenhai ^a   Wang, Cheng ^a   Hu, Yuanguo ^a   Qiu, Lujun ^a   Wang, Shijie ^a   You, Hao ^a   Zhu, Kai ^a   Xu, Peng ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cholangiocarcinoma; Cyclin D1; FHIT; QBC939

Indexed keywords

CYCLIN D1; FRAGILE HISTIDINE TRIAD PROTEIN; MESSENGER RNA;

APOPTOSIS; ARTICLE; BILE DUCT CARCINOMA; CARCINOMA CELL; CELL INVASION; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DNA SEQUENCE; FLOW CYTOMETRY; GENE EXPRESSION; GENE FUNCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ACID ANHYDRIDE HYDROLASES; APOPTOSIS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CELL LINE, TUMOR; CHOLANGIOCARCINOMA; CYCLIN D1; HUMANS; NEOPLASM PROTEINS; RNA, MESSENGER; TRANSFECTION;

EID: 80051646299     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, Croce CM, Huebner K: The human FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated T (3;8) breakpoint, is abnormal in digestive tract cancers. Cell 1996; 84(4):587-597. (Pubitemid 26071739)
2. Kannan K, Munirajan AK, Bhuvarahamurthy V, Mohanprasad BK, Shankar P, Tsuchida N, Shanmugam G: FHIT gene mutations and single nucleotide polymorphism in Indian oral and cervical squamous cell carcinomas. Oral Oncol 2000; 36(2): 189-193. (Pubitemid 30169161)
3. Chaudhuri AR, Khan IA, Prasad V, Robinson AK, Luduena RF, Barnes LD: The tumor suppressor protein Fhit. A novel interaction with tubulin. J Biol Chem 1999; 274(34):24378-24382.
4. Butler D, Collins C, Mabruk M, Walsh CB, Leader MB, Kay EW: Deletion of the FHIT gene in neoplastic and invasive cervical lesions is related to high-risk HPV infection but is independent of histopathological features. J Pathol 2000; 192(4):502-514.
5. Yuan BZ, Keek-Waggoner C, Zimonjic DB, Thorgeirsson SS, Popescu NC: Alterations of the FHIT gene in human hepatocellular carcinoma. Cancer Res 2000; 60(4):1049-1061.
6. Cao HP, Jonasson JG, Agnarsson BA, Sigbjornsdottir BI, Huebner K, Ingvarsson S: Analysis of the fragile histidine triad (FHIT) gene in lobular breast cancer. Eur J Cancer 2000; 36(12):1552-1557. (Pubitemid 30619008)
7. Zhao P, Lu Y, Zhong M, Liu L, Li B: Inverse correlation of aberrant expression of fragile histidine triad (FHIT) protein with cyclin D1 protein and prognosis in Chinese patients with cholangiocarcinoma. Acta Oncol 2008; 47(8)2008:1557-1563.
8. Gillett C, Smith P, Gregory W, Richards M, Millis R, Peters G, Barnes D: Cyclin D1 and prognosis in human breast cancer. Int J Cancer 1996; 69(2):92-99. (Pubitemid 26167163)
9. Nishida N, Fukuda Y, Komeda T, Kita R, Sando T, Furukawa M, Amenomori M, Shibagaki I, Nakao K, Ikenaga M, et al: Amplification and overexpression of the Cyclin D1 gene in aggressive human hepacellular carcinoma. Cancer Res 1994; 54(12):3107-3110. (Pubitemid 24208910)
10. Sugimaehi K, Aishima S, Taguchi K, Tanaka S, Shimada M, Kajiyama K, Sugimaehi K, Tsuneyoshi M: The role of overexpression and amplification of cyclin D1 in intrahepatic cholabgiocarcinoma. J Hepatol 2001; 35(1):74-79. (Pubitemid 32646227)
11. Huang ZQ: The status of surgical treatment of cholangiocarcinoma. Chin J Practical Surg 2007; 27(5):341-346. (Language: Chinese).
12. Patel T: Increasing incidence and mortality of primary intrahepatic cholangiocacinoma in the United States. Hepatology 2001; 33(6):1353-1357.
13. Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCt method. Methods 2001; 25(4):402-408. (Pubitemid 34164012)
14. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987; 47:3239-3425.
15. Fava G, Marzioni M, Benedetti A, Glaser S, DeMorrow S, Francis H, Alpini G: Molecular pathology of biliary tract cancers. Cancer Lett 2007; 250(2):155-167.
16. Yoo HJ, Yun BR, Kwon JH, Ahn HS, Seol MA, Lee MJ, Yu GR, Yu HC, Hong B, Choi K, Kim DG: Genetic and expression alterations in association with the sarcomatous change of cholangiocarcinoma cells. Exp Mol Med 2009; 41(2):102-115.
17. Roz L, Gramegna M, Ishii H, Croce CM, Sozzi G: Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines. PNAS USA 2002; 99(6):3615-3620. (Pubitemid 34252155)
18. Mareel M, Leroy A: Clinical, cellular, and molecular aspects of cancer invasion. Physiol Rev 2003; 83(2):337-376.
19. Burridge K, Chrzanowska-Wodnicka M: Focal adhesions, contractility, and signaling. Annu Rev Cell Dev Biol 1996; 12:463-518.